In a Supreme Court ruling that may have major consequences for the near future of medical research, the Court will soon determine whether or not human genes are patentable. At the heart of the case: Myriad Genetics has claims on patents related to two genes linked to breast and ovarian cancer. Joining me today to discuss this case is Antoinette Konski of Foley & Lardner—she’s been tracking and providing commentary on this case through the Personalized Medicine Bulletin.
Health Law Updates, Intellectual Property Updates
DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.
© LXBN | Attorney Advertising